These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33934267)

  • 1. Response to ovulation induction treatments in women with polycystic ovary syndrome as a function of serum anti-Müllerian hormone levels.
    Vagios S; Sacha CR; Hammer KC; Dimitriadis I; James KE; Bormann CL; Souter I
    J Assist Reprod Genet; 2021 Jul; 38(7):1827-1833. PubMed ID: 33934267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited ability of circulating anti-Müllerian hormone to predict dominant follicular recruitment in PCOS women treated with clomiphene citrate: a comparison of two different assays.
    Vaiarelli A; Drakopoulos P; Blockeel C; De Vos M; van de Vijver A; Camus M; Cosyns S; Tournaye H; Polyzos NP
    Gynecol Endocrinol; 2016; 32(3):227-30. PubMed ID: 26559558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.
    Mahran A; Abdelmeged A; El-Adawy AR; Eissa MK; Shaw RW; Amer SA
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4170-5. PubMed ID: 23979947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome.
    Elmashad AI
    Fertil Steril; 2011 Jun; 95(7):2342-6, 2346.e1. PubMed ID: 21514928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating anti-mullerian hormone as predictor of ovarian response to clomiphene citrate in women with polycystic ovary syndrome.
    Xi W; Yang Y; Mao H; Zhao X; Liu M; Fu S
    J Ovarian Res; 2016 Feb; 9():3. PubMed ID: 26864649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome.
    El-Halawaty S; Rizk A; Kamal M; Aboulhassan M; Al-Sawah H; Noah O; Al-Inany H
    Reprod Biomed Online; 2007 Nov; 15(5):495-9. PubMed ID: 18028738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.
    El-Mazny A; Abou-Salem N
    Gynecol Endocrinol; 2013 Sep; 29(9):826-9. PubMed ID: 23855354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study.
    Amer SA; Mahran A; Abdelmaged A; El-Adawy AR; Eissa MK; Shaw RW
    Reprod Biol Endocrinol; 2013 Dec; 11():115. PubMed ID: 24341292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of anti-Mullerian hormone in predicting the response to clomiphene citrate in unexplained infertility.
    Coskun B; Dilbaz B; Karadag B; Coskun B; Tohma YA; Dur R; Akkurt MO
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):713-717. PubMed ID: 30342657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovulation induction and intrauterine insemination in infertile women with polycystic ovary syndrome: A comparison of drugs.
    Huang S; Du X; Wang R; Li R; Wang H; Luo L; O'Leary S; Qiao J; Mol BWJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():117-121. PubMed ID: 30366343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of anti-Müllerian hormone in predicting clomiphene citrate resistance in women with polycystic ovarian syndrome.
    Gülşen MS; Ulu İ; Yıldırım Köpük Ş; Kıran G
    Gynecol Endocrinol; 2019 Jan; 35(1):86-89. PubMed ID: 30044165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone dynamics during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Dąbkowska-Huć A; Lemm M; Sikora J; Witek A; Skałba P
    Endokrynol Pol; 2013; 64(3):203-7. PubMed ID: 23873424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of response to ovulation induction using letrozole in women with polycystic ovary syndrome.
    Guo Z; Chen S; Chen Z; Hu P; Hao Y; Yu Q
    BMC Endocr Disord; 2023 Apr; 23(1):90. PubMed ID: 37098539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine insemination versus timed intercourse in ovulation induction cycles with clomiphene citrate for polycystic ovary syndrome: A retrospective cohort study.
    Atalay E; Ozaksit MG; Tokmak A; Engin-Ustun Y
    J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):805-809. PubMed ID: 31276841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotrophins for ovulation induction in women with polycystic ovarian syndrome.
    Weiss NS; Nahuis M; Bayram N; Mol BW; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2015 Sep; (9):CD010290. PubMed ID: 26350625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in serum markers of patients with PCOS during consecutive clomiphene stimulation cycles: a retrospective study.
    Hager M; Hörath S; Frigo P; Koch M; Marculescu R; Ott J
    J Ovarian Res; 2019 Oct; 12(1):91. PubMed ID: 31585548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome.
    Mumford SL; Legro RS; Diamond MP; Coutifaris C; Steiner AZ; Schlaff WD; Alvero R; Christman GM; Casson PR; Huang H; Santoro N; Eisenberg E; Zhang H; Cedars MI
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3288-96. PubMed ID: 27228369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study.
    Seckin B; Yumusak OH; Tokmak A
    J Obstet Gynaecol; 2021 Nov; 41(8):1234-1239. PubMed ID: 33624571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.